India to Colombia: Ondansetron Export Trade Route

The India to Colombia Ondansetron corridor is one of India's established pharmaceutical export routes, with 67 shipments documented worth a combined $2.4M USD. The route is dominated by BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $36.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 24.3%, placing it at rank #13 among India's top ondansetron export destinations globally.

On the import side, key buyers of Indian ondansetron in Colombia include LABORATORIOS BAXTER S.A, LABORATORIOS BAXTER S A, CIPLA COLOMBIA SAS Y/O DEPOSITO UPS and 8 others. LABORATORIOS BAXTER S.A is the single largest importer with 12 shipments valued at $928.9K USD.

India's ondansetron exports to Colombia are driven primarily by a handful of large-scale manufacturers. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, CIPLA LIMITED, CIPLA LIMITED — together account for 96% of total trade value on this route. The average shipment value of $36.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ondansetron inj bp 8 mg 4 ml 4ml ga blokser and ondansetron injection bp (8 mg/4 ml)- 4ml glass ampoule) (blokser), suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIOS BAXTER S.A is the largest importer with 12 shipments worth $928.9K USD — representing 38% of all ondansetron imports from India on this route. A total of 11 buyers are active on this corridor.